Report Detail
Global and United States Ophthalmic Drug Delivery System Market Report & Forecast 2022-2028
- RnM4389819 |
- 04 March, 2022 |
- Global |
- 98 Pages |
- QYResearch |
- Medical Devices & Consumables
Summary:
Market Analysis and Insights: Global and United States Ophthalmic Drug Delivery System Market
This report focuses on global and United States Ophthalmic Drug Delivery System market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Ophthalmic Drug Delivery System market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Implantable Ophthalmic Drug Delivery Systems accounting for % of the Ophthalmic Drug Delivery System global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospitals was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Ophthalmic Drug Delivery System market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
Global Ophthalmic Drug Delivery System Scope and Market Size
Ophthalmic Drug Delivery System market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Ophthalmic Drug Delivery System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Ophthalmic Drug Delivery System market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type, the Ophthalmic Drug Delivery System market is segmented into
Implantable Ophthalmic Drug Delivery Systems
Particulate Ophthalmic Drug Delivery Systems
Others
Segment by Application, the Ophthalmic Drug Delivery System market is segmented into
Hospitals
Clinics
Ambulatory Surgical Centers
Others
Regional and Country-level Analysis
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Landscape and Ophthalmic Drug Delivery System Market Share Analysis
Ophthalmic Drug Delivery System market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Ophthalmic Drug Delivery System business, the date to enter into the Ophthalmic Drug Delivery System market, Ophthalmic Drug Delivery System product introduction, recent developments, etc.
The major vendors covered:
Aero Pump GmbH
AptarGroup
Bausch Health
Becton Dickinson & Company
EyePoint Pharmaceuticals, Inc.
Gaplast GmbH
Gerresheimer
Nemera
Nipro Corporation
Ocular Therapeutix
Owen Mumford
Silgan Holdings Inc.
Terumo Corporation
West Pharmaceutical Services, Inc.
Kedalion Therapeutics
Re-Vana Therapeutics
Mati Therapeutics, Inc.,
Biocorp Production
Ocumedic, Inc.
Graybug Vision
Taiwan Liposome
Santen Pharmaceutical
Envisia Therapeutics
Clearside Biomedical
Table of Contents
1 Study Coverage
- 1.1 Ophthalmic Drug Delivery System Product Introduction
- 1.2 Global Ophthalmic Drug Delivery System Outlook 2017 VS 2022 VS 2028
- 1.2.1 Global Ophthalmic Drug Delivery System Sales in US$ Million for the Year 2017-2028
- 1.2.2 Global Ophthalmic Drug Delivery System Sales in Volume for the Year 2017-2028
- 1.3 United States Ophthalmic Drug Delivery System Outlook 2017 VS 2022 VS 2028
- 1.3.1 United States Ophthalmic Drug Delivery System Sales in US$ Million for the Year 2017-2028
- 1.3.2 United States Ophthalmic Drug Delivery System Sales in Volume for the Year 2017-2028
- 1.4 Ophthalmic Drug Delivery System Market Size, United States VS Global, 2017 VS 2022 VS 2028
- 1.4.1 The Market Share of United States Ophthalmic Drug Delivery System in Global, 2017 VS 2022 VS 2028
- 1.4.2 The Growth Rate of Ophthalmic Drug Delivery System Market Size, United States VS Global, 2017 VS 2022 VS 2028
- 1.5 Ophthalmic Drug Delivery System Market Dynamics
- 1.5.1 Ophthalmic Drug Delivery System Industry Trends
- 1.5.2 Ophthalmic Drug Delivery System Market Drivers
- 1.5.3 Ophthalmic Drug Delivery System Market Challenges
- 1.5.4 Ophthalmic Drug Delivery System Market Restraints
- 1.6 Study Objectives
- 1.7 Years Considered
2 Market by Type
- 2.1 Ophthalmic Drug Delivery System Market Segment by Type
- 2.1.1 Implantable Ophthalmic Drug Delivery Systems
- 2.1.2 Particulate Ophthalmic Drug Delivery Systems
- 2.1.3 Others
- 2.2 Global Ophthalmic Drug Delivery System Market Size by Type
- 2.2.1 Global Ophthalmic Drug Delivery System Sales in Value, by Type (2017, 2022 & 2028)
- 2.2.2 Global Ophthalmic Drug Delivery System Sales in Volume, by Type (2017, 2022 & 2028)
- 2.2.3 Global Ophthalmic Drug Delivery System Average Selling Price (ASP) by Type (2017, 2022 & 2028)
- 2.3 United States Ophthalmic Drug Delivery System Market Size by Type
- 2.3.1 United States Ophthalmic Drug Delivery System Sales in Value, by Type (2017, 2022 & 2028)
- 2.3.2 United States Ophthalmic Drug Delivery System Sales in Volume, by Type (2017, 2022 & 2028)
- 2.3.3 United States Ophthalmic Drug Delivery System Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
- 3.1 Ophthalmic Drug Delivery System Market Segment by Application
- 3.1.1 Hospitals
- 3.1.2 Clinics
- 3.1.3 Ambulatory Surgical Centers
- 3.1.4 Others
- 3.2 Global Ophthalmic Drug Delivery System Market Size by Application
- 3.2.1 Global Ophthalmic Drug Delivery System Sales in Value, by Application (2017, 2022 & 2028)
- 3.2.2 Global Ophthalmic Drug Delivery System Sales in Volume, by Application (2017, 2022 & 2028)
- 3.3.3 Global Ophthalmic Drug Delivery System Average Selling Price (ASP) by Application (2017, 2022 & 2028)
- 3.3 United States Ophthalmic Drug Delivery System Market Size by Application
- 3.3.1 United States Ophthalmic Drug Delivery System Sales in Value, by Application (2017, 2022 & 2028)
- 3.3.2 United States Ophthalmic Drug Delivery System Sales in Volume, by Application (2017, 2022 & 2028)
- 3.3.3 United States Ophthalmic Drug Delivery System Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Ophthalmic Drug Delivery System Competitor Landscape by Company
- 4.1 Global Ophthalmic Drug Delivery System Market Size by Company
- 4.1.1 Top Global Ophthalmic Drug Delivery System Manufacturers Ranked by Revenue (2021)
- 4.1.2 Global Ophthalmic Drug Delivery System Revenue by Manufacturer (2017-2022)
- 4.1.3 Global Ophthalmic Drug Delivery System Sales by Manufacturer (2017-2022)
- 4.1.4 Global Ophthalmic Drug Delivery System Price by Manufacturer (2017-2022)
- 4.2 Global Ophthalmic Drug Delivery System Concentration Ratio (CR)
- 4.2.1 Ophthalmic Drug Delivery System Market Concentration Ratio (CR) (2017-2022)
- 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Ophthalmic Drug Delivery System in 2021
- 4.2.3 Global Ophthalmic Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 4.3 Global Ophthalmic Drug Delivery System Manufacturing Base Distribution, Product Type
- 4.3.1 Global Ophthalmic Drug Delivery System Manufacturers, Headquarters and Distribution of Producing Region
- 4.3.2 Manufacturers Ophthalmic Drug Delivery System Product Type
- 4.3.3 Date of International Manufacturers Enter into Ophthalmic Drug Delivery System Market
- 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
- 4.5 United States Ophthalmic Drug Delivery System Market Size by Company
- 4.5.1 Top Ophthalmic Drug Delivery System Players in United States, Ranked by Revenue (2021)
- 4.5.2 United States Ophthalmic Drug Delivery System Revenue by Players (2020, 2021 & 2022)
- 4.5.3 United States Ophthalmic Drug Delivery System Sales by Players (2020, 2021 & 2022)
5 Global Ophthalmic Drug Delivery System Market Size by Region
- 5.1 Global Ophthalmic Drug Delivery System Market Size by Region: 2017 VS 2022 VS 2028
- 5.2 Global Ophthalmic Drug Delivery System Market Size in Volume by Region (2017-2028)
- 5.2.1 Global Ophthalmic Drug Delivery System Sales in Volume by Region: 2017-2022
- 5.2.2 Global Ophthalmic Drug Delivery System Sales in Volume Forecast by Region (2023-2028)
- 5.3 Global Ophthalmic Drug Delivery System Market Size in Value by Region (2017-2028)
- 5.3.1 Global Ophthalmic Drug Delivery System Sales in Value by Region: 2017-2022
- 5.3.2 Global Ophthalmic Drug Delivery System Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
- 6.1 North America
- 6.1.1 North America Ophthalmic Drug Delivery System Market Size YoY Growth 2017-2028
- 6.1.2 North America Ophthalmic Drug Delivery System Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.1.3 United States
- 6.1.4 Canada
- 6.2 Asia-Pacific
- 6.2.1 Asia-Pacific Ophthalmic Drug Delivery System Market Size YoY Growth 2017-2028
- 6.2.2 Asia-Pacific Ophthalmic Drug Delivery System Market Facts & Figures by Region (2017, 2022 & 2028)
- 6.2.3 China
- 6.2.4 Japan
- 6.2.5 South Korea
- 6.2.6 India
- 6.2.7 Australia
- 6.2.8 China Taiwan
- 6.2.9 Indonesia
- 6.2.10 Thailand
- 6.2.11 Malaysia
- 6.3 Europe
- 6.3.1 Europe Ophthalmic Drug Delivery System Market Size YoY Growth 2017-2028
- 6.3.2 Europe Ophthalmic Drug Delivery System Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.3.3 Germany
- 6.3.4 France
- 6.3.5 U.K.
- 6.3.6 Italy
- 6.3.7 Russia
- 6.4 Latin America
- 6.4.1 Latin America Ophthalmic Drug Delivery System Market Size YoY Growth 2017-2028
- 6.4.2 Latin America Ophthalmic Drug Delivery System Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.4.3 Mexico
- 6.4.4 Brazil
- 6.4.5 Argentina
- 6.5 Middle East and Africa
- 6.5.1 Middle East and Africa Ophthalmic Drug Delivery System Market Size YoY Growth 2017-2028
- 6.5.2 Middle East and Africa Ophthalmic Drug Delivery System Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.5.3 Turkey
- 6.5.4 Saudi Arabia
- 6.5.5 UAE
7 Company Profiles
- 7.1 Aero Pump GmbH
- 7.1.1 Aero Pump GmbH Corporation Information
- 7.1.2 Aero Pump GmbH Description and Business Overview
- 7.1.3 Aero Pump GmbH Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
- 7.1.4 Aero Pump GmbH Ophthalmic Drug Delivery System Products Offered
- 7.1.5 Aero Pump GmbH Recent Development
- 7.2 AptarGroup
- 7.2.1 AptarGroup Corporation Information
- 7.2.2 AptarGroup Description and Business Overview
- 7.2.3 AptarGroup Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
- 7.2.4 AptarGroup Ophthalmic Drug Delivery System Products Offered
- 7.2.5 AptarGroup Recent Development
- 7.3 Bausch Health
- 7.3.1 Bausch Health Corporation Information
- 7.3.2 Bausch Health Description and Business Overview
- 7.3.3 Bausch Health Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
- 7.3.4 Bausch Health Ophthalmic Drug Delivery System Products Offered
- 7.3.5 Bausch Health Recent Development
- 7.4 Becton Dickinson & Company
- 7.4.1 Becton Dickinson & Company Corporation Information
- 7.4.2 Becton Dickinson & Company Description and Business Overview
- 7.4.3 Becton Dickinson & Company Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
- 7.4.4 Becton Dickinson & Company Ophthalmic Drug Delivery System Products Offered
- 7.4.5 Becton Dickinson & Company Recent Development
- 7.5 EyePoint Pharmaceuticals, Inc.
- 7.5.1 EyePoint Pharmaceuticals, Inc. Corporation Information
- 7.5.2 EyePoint Pharmaceuticals, Inc. Description and Business Overview
- 7.5.3 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
- 7.5.4 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery System Products Offered
- 7.5.5 EyePoint Pharmaceuticals, Inc. Recent Development
- 7.6 Gaplast GmbH
- 7.6.1 Gaplast GmbH Corporation Information
- 7.6.2 Gaplast GmbH Description and Business Overview
- 7.6.3 Gaplast GmbH Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
- 7.6.4 Gaplast GmbH Ophthalmic Drug Delivery System Products Offered
- 7.6.5 Gaplast GmbH Recent Development
- 7.7 Gerresheimer
- 7.7.1 Gerresheimer Corporation Information
- 7.7.2 Gerresheimer Description and Business Overview
- 7.7.3 Gerresheimer Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
- 7.7.4 Gerresheimer Ophthalmic Drug Delivery System Products Offered
- 7.7.5 Gerresheimer Recent Development
- 7.8 Nemera
- 7.8.1 Nemera Corporation Information
- 7.8.2 Nemera Description and Business Overview
- 7.8.3 Nemera Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
- 7.8.4 Nemera Ophthalmic Drug Delivery System Products Offered
- 7.8.5 Nemera Recent Development
- 7.9 Nipro Corporation
- 7.9.1 Nipro Corporation Corporation Information
- 7.9.2 Nipro Corporation Description and Business Overview
- 7.9.3 Nipro Corporation Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
- 7.9.4 Nipro Corporation Ophthalmic Drug Delivery System Products Offered
- 7.9.5 Nipro Corporation Recent Development
- 7.10 Ocular Therapeutix
- 7.10.1 Ocular Therapeutix Corporation Information
- 7.10.2 Ocular Therapeutix Description and Business Overview
- 7.10.3 Ocular Therapeutix Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
- 7.10.4 Ocular Therapeutix Ophthalmic Drug Delivery System Products Offered
- 7.10.5 Ocular Therapeutix Recent Development
- 7.11 Owen Mumford
- 7.11.1 Owen Mumford Corporation Information
- 7.11.2 Owen Mumford Description and Business Overview
- 7.11.3 Owen Mumford Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
- 7.11.4 Owen Mumford Ophthalmic Drug Delivery System Products Offered
- 7.11.5 Owen Mumford Recent Development
- 7.12 Silgan Holdings Inc.
- 7.12.1 Silgan Holdings Inc. Corporation Information
- 7.12.2 Silgan Holdings Inc. Description and Business Overview
- 7.12.3 Silgan Holdings Inc. Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
- 7.12.4 Silgan Holdings Inc. Products Offered
- 7.12.5 Silgan Holdings Inc. Recent Development
- 7.13 Terumo Corporation
- 7.13.1 Terumo Corporation Corporation Information
- 7.13.2 Terumo Corporation Description and Business Overview
- 7.13.3 Terumo Corporation Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
- 7.13.4 Terumo Corporation Products Offered
- 7.13.5 Terumo Corporation Recent Development
- 7.14 West Pharmaceutical Services, Inc.
- 7.14.1 West Pharmaceutical Services, Inc. Corporation Information
- 7.14.2 West Pharmaceutical Services, Inc. Description and Business Overview
- 7.14.3 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
- 7.14.4 West Pharmaceutical Services, Inc. Products Offered
- 7.14.5 West Pharmaceutical Services, Inc. Recent Development
- 7.15 Kedalion Therapeutics
- 7.15.1 Kedalion Therapeutics Corporation Information
- 7.15.2 Kedalion Therapeutics Description and Business Overview
- 7.15.3 Kedalion Therapeutics Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
- 7.15.4 Kedalion Therapeutics Products Offered
- 7.15.5 Kedalion Therapeutics Recent Development
- 7.16 Re-Vana Therapeutics
- 7.16.1 Re-Vana Therapeutics Corporation Information
- 7.16.2 Re-Vana Therapeutics Description and Business Overview
- 7.16.3 Re-Vana Therapeutics Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
- 7.16.4 Re-Vana Therapeutics Products Offered
- 7.16.5 Re-Vana Therapeutics Recent Development
- 7.17 Mati Therapeutics, Inc.,
- 7.17.1 Mati Therapeutics, Inc., Corporation Information
- 7.17.2 Mati Therapeutics, Inc., Description and Business Overview
- 7.17.3 Mati Therapeutics, Inc., Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
- 7.17.4 Mati Therapeutics, Inc., Products Offered
- 7.17.5 Mati Therapeutics, Inc., Recent Development
- 7.18 Biocorp Production
- 7.18.1 Biocorp Production Corporation Information
- 7.18.2 Biocorp Production Description and Business Overview
- 7.18.3 Biocorp Production Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
- 7.18.4 Biocorp Production Products Offered
- 7.18.5 Biocorp Production Recent Development
- 7.19 Ocumedic, Inc.
- 7.19.1 Ocumedic, Inc. Corporation Information
- 7.19.2 Ocumedic, Inc. Description and Business Overview
- 7.19.3 Ocumedic, Inc. Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
- 7.19.4 Ocumedic, Inc. Products Offered
- 7.19.5 Ocumedic, Inc. Recent Development
- 7.20 Graybug Vision
- 7.20.1 Graybug Vision Corporation Information
- 7.20.2 Graybug Vision Description and Business Overview
- 7.20.3 Graybug Vision Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
- 7.20.4 Graybug Vision Products Offered
- 7.20.5 Graybug Vision Recent Development
- 7.21 Taiwan Liposome
- 7.21.1 Taiwan Liposome Corporation Information
- 7.21.2 Taiwan Liposome Description and Business Overview
- 7.21.3 Taiwan Liposome Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
- 7.21.4 Taiwan Liposome Products Offered
- 7.21.5 Taiwan Liposome Recent Development
- 7.22 Santen Pharmaceutical
- 7.22.1 Santen Pharmaceutical Corporation Information
- 7.22.2 Santen Pharmaceutical Description and Business Overview
- 7.22.3 Santen Pharmaceutical Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
- 7.22.4 Santen Pharmaceutical Products Offered
- 7.22.5 Santen Pharmaceutical Recent Development
- 7.23 Envisia Therapeutics
- 7.23.1 Envisia Therapeutics Corporation Information
- 7.23.2 Envisia Therapeutics Description and Business Overview
- 7.23.3 Envisia Therapeutics Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
- 7.23.4 Envisia Therapeutics Products Offered
- 7.23.5 Envisia Therapeutics Recent Development
- 7.24 Clearside Biomedical
- 7.24.1 Clearside Biomedical Corporation Information
- 7.24.2 Clearside Biomedical Description and Business Overview
- 7.24.3 Clearside Biomedical Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
- 7.24.4 Clearside Biomedical Products Offered
- 7.24.5 Clearside Biomedical Recent Development
8 Industry Chain and Sales Channels Analysis
- 8.1 Ophthalmic Drug Delivery System Industry Chain Analysis
- 8.2 Ophthalmic Drug Delivery System Key Raw Materials
- 8.2.1 Key Raw Materials
- 8.2.2 Ophthalmic Drug Delivery System Distributors
- 8.3 Ophthalmic Drug Delivery System Production Mode & Process
- 8.4 Ophthalmic Drug Delivery System Sales and Marketing
- 8.4.1 Ophthalmic Drug Delivery System Sales Channels
- 8.4.2 Ophthalmic Drug Delivery System Distributors
- 8.5 Ophthalmic Drug Delivery System Customers
9 Research Findings and Conclusion
10 Appendix
- 10.1 Research Methodology
- 10.1.1 Methodology/Research Approach
- 10.1.2 Data Source
- 10.2 Author Details
Summary:
Get latest Market Research Reports on Ophthalmic Drug Delivery System. Industry analysis & Market Report on Ophthalmic Drug Delivery System is a syndicated market report, published as Global and United States Ophthalmic Drug Delivery System Market Report & Forecast 2022-2028. It is complete Research Study and Industry Analysis of Ophthalmic Drug Delivery System market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
